老虎證券

美股詳情
本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Innate Pharma SA

2.00
-0.0400-1.96%
成交量：1.83萬
成交額：3.66萬
市值：1.84億
市盈率：-3.17
高：2.12
開：2.00
低：1.93
收：2.04
52周最高：3.51
52周最低：1.29
股本：9,218.55萬
流通股本：5,922.40萬
量比：1.40
換手率：0.03%
股息：- -
股息率：- -
每股收益(TTM):-0.6319
每股收益(LYR):-0.6319
淨資產收益率：-162.91%
總資產收益率：-22.52%
市淨率：17.79
市盈率(LYR):-3.17

資料載入中...

總覽公司新聞公告
2025/05/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/04/30

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/09/11

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/04/04

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/01/12

SEC問詢函

Form CORRESP - Correspondence
2023/04/20

[修訂]年度報告

20-F/A [Amend] - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/04/06

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/12/06

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/10/21

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/04/04

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/07/12

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/05/11

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/04/27

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/03/16

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/02/12

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/01/27

SEC問詢函

CORRESP [Cover] - Correspondence
2020/04/24

年度報告

Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/04/14

非美公司披露報告

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/04/14

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/10

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
更多